Suppr超能文献

通过诱导细胞凋亡和抑制细胞转移将止泻药洛哌丁胺重新用于治疗黑色素瘤

Repurposing of Antidiarrheal Loperamide for Treating Melanoma by Inducing Cell Apoptosis and Cell Metastasis Suppression and .

作者信息

Yang Shuping, Li Zhi, Pan Mingyue, Ma Jing, Pan Zeyu, Zhang Peng, Cao Weiling

机构信息

Department of Pharmacy, Shenzhen Luohu People's Hospital, Shenzhen, Guangdong, China.

Department of Pharmacy, South China Hospital, Medical School, Shenzhen University, Shenzhen, P.R. China.

出版信息

Curr Cancer Drug Targets. 2024;24(10):1015-1030. doi: 10.2174/0115680096283086240116093400.

Abstract

BACKGROUND

Melanoma is the most common skin tumor worldwide and still lacks effective therapeutic agents in clinical practice. Repurposing of existing drugs for clinical tumor treatment is an attractive and effective strategy. Loperamide is a commonly used anti-diarrheal drug with excellent safety profiles. However, the affection and mechanism of loperamide in melanoma remain unknown. Herein, the potential anti-melanoma effects and mechanism of loperamide were investigated and .

METHODS

In the present study, we demonstrated that loperamide possessed a strong inhibition in cell viability and proliferation in melanoma using MTT, colony formation and EUD incorporation assays. Meanwhile, xenograft tumor models were established to investigate the anti-melanoma activity of loperamide . Moreover, the effects of loperamide on apoptosis in melanoma cells and potential mechanisms were explored by Annexin V-FITC apoptosis detection, cell cycle, mitochondrial membrane potential assay, reactive oxygen species level detection, and apoptosis-correlation proteins analysis. Furthermore, loperamide-suppressed melanoma metastasis was studied by migration and invasion assays. What's more, immunohistochemical and immunofluorescence staining assays were applied to demonstrate the mechanism of loperamide against melanoma . Finally, we performed the analysis of routine blood and blood biochemical, as well as hematoxylin- eosin (H&E) staining, in order to investigate the safety properties of loperamide.

RESULTS

Loperamide could observably inhibit melanoma cell proliferation and . Meanwhile, loperamide induced melanoma cell apoptosis by accumulation of the sub-G1 cells population, enhancement of reactive oxygen species level, depletion of mitochondrial membrane potential, and apoptosis-related protein activation . Of note, apoptosis-inducing effects were also observed in vivo. Subsequently, loperamide markedly restrained melanoma cell migration and invasion and . Ultimately, loperamide was witnessed to have an amicable safety profile.

CONCLUSION

These findings suggested that repurposing of loperamide might have great potential as a novel and safe alternative strategy to cure melanoma inhibiting proliferation, inducing apoptosis and cell cycle arrest, and suppressing migration and invasion.

摘要

背景

黑色素瘤是全球最常见的皮肤肿瘤,临床实践中仍缺乏有效的治疗药物。将现有药物重新用于临床肿瘤治疗是一种有吸引力且有效的策略。洛哌丁胺是一种常用的止泻药,具有出色的安全性。然而,洛哌丁胺对黑色素瘤的影响及机制尚不清楚。在此,研究了洛哌丁胺潜在的抗黑色素瘤作用及其机制。

方法

在本研究中,我们通过MTT法、集落形成实验和EUD掺入实验证明洛哌丁胺对黑色素瘤细胞活力和增殖具有强烈抑制作用。同时,建立异种移植肿瘤模型以研究洛哌丁胺的抗黑色素瘤活性。此外,通过膜联蛋白V-FITC凋亡检测、细胞周期、线粒体膜电位检测、活性氧水平检测和凋亡相关蛋白分析,探讨了洛哌丁胺对黑色素瘤细胞凋亡的影响及其潜在机制。此外,通过迁移和侵袭实验研究了洛哌丁胺抑制黑色素瘤转移的作用。更重要的是,应用免疫组织化学和免疫荧光染色实验来证明洛哌丁胺抗黑色素瘤的机制。最后,我们进行了血常规和血液生化分析以及苏木精-伊红(H&E)染色,以研究洛哌丁胺的安全性。

结果

洛哌丁胺可显著抑制黑色素瘤细胞增殖。同时,洛哌丁胺通过亚G1期细胞群体的积累、活性氧水平的升高、线粒体膜电位的耗竭以及凋亡相关蛋白的激活诱导黑色素瘤细胞凋亡。值得注意的是,在体内也观察到了凋亡诱导作用。随后,洛哌丁胺显著抑制黑色素瘤细胞的迁移和侵袭。最终,洛哌丁胺具有良好的安全性。

结论

这些发现表明,将洛哌丁胺重新用于治疗黑色素瘤可能具有巨大潜力,它可作为一种新型且安全的替代策略,通过抑制增殖、诱导凋亡和细胞周期停滞以及抑制迁移和侵袭来治愈黑色素瘤。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验